Primary Hyperoxaluria Type 3
What's New
Last Posted: Jan 27, 2024
- Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants.
Pavla Vankova, et al. FEBS letters 2024 0 - Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
Elisabeth L Metry, et al. Kidney international reports 2023 0 (10) 2029-2042 - HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype-phenotype relationships.
Yucheng Ge, et al. World journal of urology 2023 0 - siRNAs-A New Class of Medicines.
Anastasia Khvorova et al. JAMA 2023 6 - Kidney cysts in patients with HOGA1 variants.
Patel Dipal M, et al. Clinical nephrology 2023 0 - Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review.
Du Dun-Feng, et al. Current medical science 2018 0 (5) 749-757 - [Inherited kidney stones: A nephrology center experience].
Kaaroud H, et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2019 0 (16) 962-973 - Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.
Bar Roi, et al. The Journal of urology 2020 0 (5) 1394-1399 - Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations.
Zhao Fangzhou, et al. Urolithiasis 2020 0 (1) 17-25 - Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1.
Murad Hossam, et al. BMC medical genomics 2021 0 (1) 146
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: